what is the likelihood of getting cancer from zantac?
Risk of cancer appeared significantly lower with ranitidine versus famotidine for most individual cancers as well, with odds ratios of 0.54 to 0.99 and 95% confidence intervals below 1.0 for cancers of the colon/rectum/pancreas, lung, bladder, uterus, prostate, breast, and liver.